The Latest

• 

  Boston Scientific to buy Intera Oncology, maker of liver cancer treatment

  Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.

  Medical Devices

• 

  Johns Hopkins surgeon Makary is Trump’s pick to lead FDA

  A prolific medical researcher and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

  FDA

• 

  Medtronic, Tempus testing AI to find potential TAVR patients

  The randomized trial will use Tempus’ platform to find patients who are eligible for interventions such as TAVR but do not have a treatment plan in place.

  Clinical Trials

• 

  Medtronic buys surgical instrument developer Fortimedix

  Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.

  Medical Devices

• 

  FDA plan would alert public sooner on high-risk device recalls

  The Center for Devices and Radiological Health’s pilot program is meant to cut the time between the FDA’s awareness of potentially high-risk recalls and when the public is notified.

  Medical Devices

• 

  Medtronic nets FDA nod for smart insulin pen app

  The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous glucose monitor for people who take multiple daily insulin injections.

  Medical Devices

• 

  Healthcare industry braces for RFK Jr.

  Kennedy's views on vaccines in particular are causing alarm among some physicians and investors.

  COVID-19

• 

  Henry Schein to acquire medical supplier Acentus

  Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.

  M&A

• 

  Verily alum looks to improve access to retinal scans

  CEO Vicky Demas joined Identifeye Health, a startup building an AI-supported retinal imaging device, after stints with Google’s sibling Verily and Grail.

  Medical Devices

• 

  Philips revises ventilator directions after airflow issue tied to 4 injuries

  Aerosol deposits could accumulate on a sensor and affect oxygen delivery, the FDA said in a recall notice. Several of the ventilator models were previously recalled for separate problems.

  Medical Devices

• 

  Advamed CEO welcomes Dr. Oz as Trump’s pick to lead CMS

  Scott Whitaker said Mehmet Oz knows firsthand the impact of medical technologies on disease prevention and treatment. Oz holds a patent on Abbott’s Mitraclip heart device.

  Medical Devices

• 

  Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs

  The partnership will support data flows that enable people who use both companies’ devices to track how glucose levels affect other health metrics.

  Digital Health

• 

  Labcorp hires Julia Wang as CFO

  Wang will replace Glenn Eisenberg, who is retiring after 10 years in the role. Evercore analysts called Eisenberg a Labcorp “institution.”

  Diagnostics

• 

  Trump nominates Dr. Oz to oversee Medicare, Medicaid as CMS head

  On Truth Social, President-elect Donald Trump said Oz, who is best known for his eponymous TV show, would take on the “illness industrial complex.” 

  Medical Devices

• 

  Medtronic’s ablation sales slowed by PFA supply issues

  CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues that have now been resolved.

  Medical Devices

• 

  Abbott opens plant in Ireland to boost Libre 3 sensor production

  More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

  Medical Devices

• 

  The PFA race is heating up. Here’s where the market stands after J&J’s approval.

  Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space as new devices and heart imaging technology hit the market.

  Medical Devices

• 

  Boston Scientific’s Watchman could be new option for patients post ablation: study

  The trial compared the stroke prevention device for left atrial appendage closure to blood thinners in people who underwent cardiac ablation for AFib.

  Clinical Trials

• 

  FDA warns providers on Getinge devices tied to 17 serious injuries

  Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices to its shortages list following the recall.

  Medical Devices

• 

  Health systems band together to test and publicly rank top AI models

  Mass General Brigham, Emory and other providers will assess different AI models from companies like Google, Microsoft and Amazon.

  AI

• 

  Boston Scientific closes $3.7B Axonics deal after lengthy review

  Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission requested more information.

  Medical Devices

• 

  Thermo Fisher eliminating 160 jobs, closing Massachusetts facility

  A facility in Lexington will close, and smaller numbers of people will be laid off at plants in Cambridge and Plainville.

  Medical Devices

• 

  Trump nominates RFK Jr. to lead HHS

  The nomination of a prominent vaccine skeptic to the head of the nation’s largest healthcare program is expected to alarm some public health experts.

  Medical Devices

• 

  Haemonetics to close California facility, lay off 75 people

  Over the past year, Haemonetics has reshaped its product portfolio through restructuring and M&A, adding devices used in cardiology procedures.

  Medical Devices

• 

  FDA breakthrough device decisions rebound after recent declines

  The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the downward trend seen as the COVID-19 pandemic eased.

  Medical Devices

More stories